Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 43.10M | $ 16.83M | $ 38.90M | $ 21.32M | $ 27.86M |
Total Assets | $ 102.09M | $ 60.93M | $ 59.59M | $ 32.35M | $ 33.60M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 15.55M | $ 4.96M | $ 3.46M | $ 1.25M | $ 1.26M |
Stockholders Equity | $ 87.64M | $ 56.65M | $ 56.42M | $ 31.10M | $ 32.34M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |